FY 2013 Cooperative Agreement for the Physician Clinical Support System - Medication Assisted Treatment — Substance Abuse and Mental Health Services Adminis funding opportunity
Substance Abuse and Mental Health Services Adminis · Federal agency

FY 2013 Cooperative Agreement for the Physician Clinical Support System - Medication Assisted Treatment

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2013 Cooperative Agreement for the Physician Clinical Sup...

65
match
Award $0–$1M Deadline 4829 days ago Location Alabama Type grant Level Federal Closed posted Feb 13, 2013
✦ AI Summary
  • Who can apply: Federal-level applicants (see eligibility for details).
  • Funding amount: up to $1,000,000 (total pool ~$1,000,000).
  • Next deadline: April 1, 2013.
  • Issued by: Substance Abuse and Mental Health Services Adminis.
Sign in to generate AI summary
How was this generated?

The “key facts” mode pulls structured fields directly from the official source posting (amount, deadline, eligibility tags). The AI mode adds a short plain-English narrative on top, generated from the same source. Always verify with the agency before applying.

AI-generated. Always verify with the official source.

Award amount
$0–$1M
Deadline
4829 days ago
Apr 1, 2013
Total pool
$1M

About this opportunity

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY) 2013 Cooperative Agreement for the Physician Clinical Support System - Medication Assisted Treatment grant. The purpose of this program is to build upon the current SAMHSA-funded Physician Clinical Support System – Buprenorphine (PCSS-B) a national mentoring network offering support (clinical updates, evidence-based outcomes and training) by expanding the focus on buprenorphine to include the other two FDA approved medications for the treatment of opioid addiction, methadone and extended release naltrexone and increasing the amount of training for office based physicians and opioid treatment program medical professionals. The program will provide up to date and evidence-based information to support training of health professionals and to address complex issues of addiction. In October 2002, the Food and Drug Administration (FDA) approved buprenorphine (Subutex ®) and buprenorphine combined with naloxone (Suboxone ®) as sublingual tablet preparations indicated for detoxification and long-term therapy in opioid dependency. These are the only two schedule III medications approved by the FDA for treatment of opioid addiction under the Drug Addiction Treatment of 2000. Subsequently, SAMHSA established the PCSS-B to (a) support physicians in the workforce who are providing buprenorphine treatment, (b) promote strategies that address practical issues in the recognition and treatment of opioid addiction through the use of multiple training formats and technologies, (c) target primary care physicians who are trying to integrate opioid addiction into their practice, and (d) provide advanced training that addresses more complex issues in the treatment of opioid use disorders. More recently, on October 12, 2010, the FDA approved extended release injectible naltrexone (Vivitrol ®) to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment. Extended release injectible naltrexone is a non-narcotic product that provides an alternative to the two more widely used and controlled substances, methadone (schedule II) and buprenorphine. While there has been a significant increase in the number of persons who have been prescribed buprenorphine for opioid addiction treatment in the past several years, the number of people who have been inducted on extended release injectible naltrexone remains relatively low in part due to the lack of education and knowledge by primary care physicians about opioid addiction and this medication. Thus, training in the appropriate use and indications for extended release injectible naltrexone is highly needed. The overall lack of physician training, concerns over practical issues, and limited understanding of the appropriate role of medication in opioid treatment also appear to be factors in the slow adoption of newer forms of opioid treatment by the medical profession. Thus, this program is designed to carry out the training of physicians desiring to prescribe and/or dispense FDA approved products (buprenorphine, methadone and naltrexone, including extended release injectible naltrexone) for the treatment of opioid addictive disorders. By enlisting the assistance of addiction medicine and psychiatry medical specialty organizations and other organizations that focus on opioid addiction, medication assisted treatment, and recovery from opioid addiction, the grantee will offer physicians, substance abuse specialists, and other health professions the information and consultation they need to provide effective pharmacologic treatment for opioid dependence, thereby reducing resistance and barriers to the availability of treatment.

Funding agency

Substance Abuse and Mental Health Services Adminis
Federal agency

Tags

Healthcare & Biotech Education & Research Transportation & Logistics Science, Tech & Engineering (STEM)
Want help applying?

Our specialists will check your eligibility, prepare the application, and walk you through every step — for free. Create a free account →

Who can apply

Eligibility details aren't on file yet — check the agency source link in the Documents tab for the latest rules.

Geographic eligibility

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • West Virginia
  • Wisconsin
  • Wyoming
  • District of Columbia

How to apply

We don't have application instructions on file yet — head straight to the official source.

Apply on agency site
Tip from our team:

Read the agency's eligibility checklist before you start — it's almost always shorter than the full NOFO and will tell you in 90 seconds whether to keep going.

Need help getting in touch with the right agency contact?

Create a free account and our specialists will guide you through the application end-to-end.

Source documents

View on agency site
Canonical NOFO, application packet, and forms
No supplemental documents yet.

Direct downloads (NOFO PDFs, application forms, FAQs) will appear here once our team attaches them. For now, the agency site has the canonical packet.

Citation details

Source systemgrants.gov
Source ID220594
PostedFeb 13, 2013

Frequently asked questions

No FAQs yet.

Have a question about this fund? Sign in to open a ticket about this fund.

Similar grants

Construction & Housing
Transportation Department

Notice of Funding Opportunity for the Fiscal Year 2025 and 2026 Consolidated Rail Infrastructure and Safety Improvements Program

83
match

- **Who can apply:** Federal-level applicants (see eligibility for details). - **Issued by:** Transportation Department. - **About:** The Federal Railroad Administration has published a Notice of Funding Opportunity (…

Amount varies Rolling Nationwide, USA
Transportation & Logistics
Transportation Department

Notice of Funding Opportunity for the Fiscal Years 2025-2026 Federal-State Partnership for Intercity Passenger Rail Program for Projects Located on the Northeast Corridor (Partnership-NEC)

97
match

- **Who can apply:** Federal-level applicants (see eligibility for details). - **Issued by:** Transportation Department. - **About:** The Federal Railroad Administration has published a Notice of Funding Opportunity (…

Amount varies Rolling Nationwide, USA
Agriculture & Farming
Department of Resources Recycling and Recovery

Farm and Ranch Solid Waste Cleanup and Abatement Grant Program FR91

71
match

Purpose: The Farm & Ranch Solid Waste Clean Up & Abatement Grant program provides funding for cleaning up and preventing illegal dumping on agricultural properties (CCR, Section 17991(d)). Each fiscal year has four ap…

Amount varies Rolling California, USA
Nonprofit & Community
CA State Library

2026-2027 LSTA Digital Literacy and Access

68
match

Purpose: Public libraries provide access to digital resources and the skills to safely use those resources, which are key components of the Broadband for All Initiative . The goals of this opportunity are to help libr…

Amount varies Rolling California, USA
Apply on agency site